Division of Genetics and Genomic Medicine, Department of Pediatrics, University of California, Irvine, Orange, California.
Neuromuscular Program, Department of Neurology, University of California, Irvine, Orange, California.
Clin Genet. 2018 Jan;93(1):119-125. doi: 10.1111/cge.13095.
Mutations in valosin-containing protein (VCP), an ATPase involved in protein degradation and autophagy, cause VCP disease, a progressive autosomal dominant adult onset multisystem proteinopathy. The goal of this study is to examine if phenotypic differences in this disorder could be explained by the specific gene mutations. We therefore studied 231 individuals (118 males and 113 females) from 36 families carrying 15 different VCP mutations. We analyzed the correlation between the different mutations and prevalence, age of onset and severity of myopathy, Paget's disease of bone (PDB), and frontotemporal dementia (FTD), and other comorbidities. Myopathy, PDB and FTD was present in 90%, 42% and 30% of the patients, respectively, beginning at an average age of 43, 41, and 56 years, respectively. Approximately 9% of patients with VCP mutations had an amyotrophic lateral sclerosis (ALS) phenotype, 4% had been diagnosed with Parkinson's disease (PD), and 2% had been diagnosed with Alzheimer's disease (AD). Large interfamilial and intrafamilial variation made establishing correlations difficult. We did not find a correlation between the mutation type and the incidence of any of the clinical features associated with VCP disease, except for the absence of PDB with the R159C mutation in our cohort and R159C having a later age of onset of myopathy compared with other molecular subtypes.
突变位于包含缬氨酸蛋白(VCP),一种参与蛋白降解和自噬的 ATP 酶,导致 VCP 疾病,一种进行性常染色体显性成人发病的多系统蛋白病。本研究的目的是检验该疾病的表型差异是否可以用特定基因突变来解释。因此,我们研究了 36 个家系的 231 名个体(118 名男性和 113 名女性),携带 15 种不同的 VCP 突变。我们分析了不同突变与肌病、Pagets 骨病(PDB)、额颞叶痴呆(FTD)和其他合并症的患病率、发病年龄和严重程度之间的相关性。肌病、PDB 和 FTD 分别在 90%、42%和 30%的患者中出现,发病年龄平均分别为 43、41 和 56 岁。大约 9%的 VCP 突变患者有肌萎缩侧索硬化(ALS)表型,4%有帕金森病(PD)诊断,2%有阿尔茨海默病(AD)诊断。大的家族内和家族间的变异性使得建立相关性变得困难。我们没有发现突变类型与 VCP 疾病相关的任何临床特征的发生率之间存在相关性,除了我们的队列中 R159C 突变与 PDB 缺失以及 R159C 与其他分子亚型相比肌病发病年龄较晚之外。